CompoAtlas

HylaFluid

Natural health product licensed in Canada

Other names
HA Combo Liquid, HA For Joints, HA Whole Body, Hyaluronic Acid Liquid Combo, Hyaluronic Acid Liquid Professional, Hyaluronic Acid Pro, Liquid HA, Whole Body HA
Licence holder
Hyalogic LLC
NPN or DIN-HM
80066299
Status
Inactive licence
Licence date
8 January 2016
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide hyaluronique

Source : Streptococcus equi - capsule extracellulaire bactérienne

60 milligrammeNot calculated
Sulfone de diméthyl60 milligrammeNot calculated
Zinc

Source : Citrate de zinc

3.07 milligrammeNot calculated

Non-medicinal ingredients

Eau

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Cuillère à thé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps support joint health. Helps in connective tissue formation. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain immune function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80066299

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line